Fingerprint
Dive into the research topics of 'Individualized patient dosing in phase I clinical trials: The role of Escalation with Overdose Control in PNU-214936'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Individualized patient dosing in phase I clinical trials: The role of Escalation with Overdose Control in PNU-214936
Jonathan D. Cheng, James S. Babb, Corey Langer, Steinar Aamdal, Francisco Robert, Lars Rupert Engelhardt, Olov Fernberg, Joan Schiller, Goran Forsberg, R. Katherine Alpaugh, Louis M. Weiner, André Rogatko
Research output: Contribution to journal › Article › peer-review
69
Scopus
citations